Human papillomaviruses (HPVs) cause cancer at multiple anatomic sites in men and
women, including cervical, oropharyngeal, anal, vulvar and vaginal cancers in women and …

Human papilloma virus (HPV) vaccination has been implemented in several countries for
about the past 7 years, mainly in the adolescent female population, with varying coverage …

Persistent infection with oral HPV16 is believed to drive the development of most
oropharyngeal cancers. However, patterns of oral HPV16 persistence remain understudied …

Cervical cancer is the fourth most common cancer in women and is almost exclusively
caused by human papillomavirus (HPV) infection. HPV is also frequently associated with …

Background Protection from naturally acquired human papillomavirus (HPV) antibodies may
influence HPV infection across the lifespan. This study describes seroconversion rates …

It is unclear whether a woman's age influences her risk of cervical intraepithelial neoplasia
grade 3 or worse (CIN3+) upon detection of HPV. A large change in risk as women age …

High risk human papillomavirus (HPV) infection is the major cause of cervical cancer.
Bacterial vaginosis (BV) is considered as the most prevalent vaginal imbalance affecting …

A specific immune response to human papillomavirus (HPV) in the cervical
microenvironment plays a key role in eradicating infection and eliminating mutated cells …

Objective Evaluation of the long‐term HPV‐16/18 AS 04‐adjuvanted vaccine
immunogenicity persistence in women. Design Multicentre, open‐label, long‐term follow‐up …

To investigate the prevalence and genotype distribution of human papillomavirus (HPV)
infection among women in urban Tianjin, China. A cervical cancer screening program for …